Arcadia Biosciences to Join Russell Microcap® Index
Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.
"Arcadia's inclusion in the Russell Microcap Index will increase investor awareness and broaden our investor base at a time when we are focused on scaling revenues through the sales of our GoodHempTM and GoodWheatTM seed and grain, as well as the introduction of our Hawaiian CBD products to the market this year," said
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately
For more information on the Russell Microcap Index and the Russell indexes reconstitution, go to the "Russell Reconstitution" section on the FTSE Russell website, www.ftserussell.com.
About FTSE Russell
FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies. Covering 98% of the investable market, FTSE Russell indexes offer a true picture of global markets, combined with the specialist knowledge gained from developing local benchmarks around the world. For more information, visit www.ftserussell.com.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including the scaling of revenues and the introduction of new products to market. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: Arcadia's and its partners' and affiliates' ability to develop and sell commercial products incorporating their traits, and complete the regulatory review process for such products; the adequacy of hemp seed demand and pricing to support our projections; Arcadia's compliance with laws and regulations that impact Arcadia's business, and changes to such laws and regulations; the potential impact of COVID-19 on our business; and the company's future capital requirements and ability to satisfy its capital needs. Further information regarding these and other factors that could affect the company's financial results is included in filings the company makes with the
View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-to-join-russell-microcap-index-301078448.html
Pam Haley, Chief Financial Officer, email@example.com, LinkedIn: Arcadia Biosciences, Twitter: @ArcadiaAg